Desheng Weng

Specializzazione: Clinical oncologist
Studio medico: Cina, Canton, Sun Yat-sen University Cancer Center (SYSUCC)
Desheng Weng è uno specialista presso il Sun Yat-sen University Cancer Center, dove ricopre il ruolo di professore associato e vicedirettore del Centro di Bioterapia / Oncologia Medica del Melanoma e del Sarcoma. Il suo lavoro spazia dalla genetica del cancro — indagando i geni oncosoppressori come ING2, TESTIN, BATF2, LZAP e BIN1 nel carcinoma epatocellulare primario e nel cancro gastrico — all'immunoterapia oncologica come approccio terapeutico completo. Il suo focus clinico-ricercativo include il melanoma e il sarcoma, insieme all'assistenza oncologica basata sull'immunoterapia.
Desheng Weng è uno specialista presso il Sun Yat-sen University Cancer Center, dove ricopre il ruolo di professore associato e vicedirettore del Centro di Bioterapia / Oncologia Medica del Melanoma e del Sarcoma. Combina la ricerca sulla genetica del cancro con l'assistenza oncologica incentrata sull'immunoterapia. La sua ricerca include lo studio dei geni oncosoppressori come ING2, TESTIN, BATF2, LZAP e BIN1 e i loro legami con le caratteristiche cliniche nel carcinoma epatocellulare e nel cancro gastrico.

Servizi medici

Screening genetico

Com'è andata la tua esperienza?

1 di 3

Le informazioni su questo medico sono complete e chiare

Totalmente in disaccordo

Totalmente d'accordo

Formazione accademica

Desheng Weng works as a specialist at Sun Yat-sen University Cancer Center, holding the roles of Associate Professor and Deputy Director in the Biotherapy Center and Melanoma and Sarcoma Medical Oncology. His research program connects cancer genetics with immunotherapy, reflecting a biotherapy-centered approach to treating melanoma and sarcoma. In cancer genetics studies, his work includes tumor suppressor gene down-regulation and evaluating genes such as ING2, TESTIN, BATF2, LZAP, and BIN1 in primary hepatocellular carcinoma and gastric cancer. He also investigates how these tumor suppressors relate to clinicopathological parameters and explores their functional roles through in vitro assays such as proliferation, clone formation, motility, invasion, and apoptosis of tumor cell lines. Alongside genetics, Weng’s profile highlights immunotherapy as an important comprehensive method for cancer patients. For international patients, this means he participates in a program where treatment planning is informed by both tumor biology and immunotherapy concepts.

Education

Education details are not specified in the provided profile materials.

Work experience

Associate Professor and Deputy Director, Biotherapy Center / Melanoma and Sarcoma Medical Oncology, Sun Yat-sen University Cancer Center (current role).

Clinical focus and techniques

At Sun Yat-sen University Cancer Center, Desheng Weng’s clinical-research focus centers on immunotherapy and biotherapy for melanoma and sarcoma, supported by cancer genetics work.

Cancer immunotherapy as a comprehensive treatment approach.
Cancer genetics research, including tumor suppressor gene expression studies (ING2, TESTIN, BATF2, LZAP, BIN1).
Functional evaluation using in vitro proliferation, clone formation, motility, invasion, and apoptosis assays.

Professional societies and certifications

Memberships and certifications are not specified in the provided profile materials.

Academic output

Publication and citation metrics are not specified in the provided profile materials.

Courses and advanced training

Courses and advanced training are not specified in the provided profile materials.

Awards and recognition

Awards are not specified in the provided profile materials.

Desheng Weng’s role at Sun Yat-sen University Cancer Center places him within a biotherapy and immunotherapy environment for melanoma and sarcoma. The profile materials do not specify spoken languages.